{
    "organizations": [],
    "uuid": "5e5c0519a804a4697ddf997401a6789d6fba72b3",
    "author": "",
    "url": "https://www.reuters.com/article/brief-vaxart-announces-5-mln-inavir-reve/brief-vaxart-announces-5-mln-inavir-revenue-milestone-idUSFWN1RX0NA",
    "ord_in_thread": 0,
    "title": "BRIEF-Vaxart Announces $5 Mln Inavir Revenue Milestone",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20, 2018 / 12:08 PM / in 14 minutes BRIEF-Vaxart Announces $5 Mln Inavir Revenue Milestone Reuters Staff \nApril 20 (Reuters) - Vaxart Inc: * VAXART ANNOUNCES $5 MILLION INAVIR® REVENUE MILESTONE \n* VAXART - NOTIFIED BY DAIICHI SANKYO CO THAT SALES OF INAVIR EXCEEDED ¥20 BILLION IN FISCAL YEAR 2017, TRIGGERING A $5 MILLION MILESTONE PAYMENT TO CO \n* VAXART INC - PAYMENT IS EXPECTED IN Q2 OF 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-04-20T15:06:00.000+03:00",
    "crawled": "2018-04-20T15:27:50.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "minute",
        "announces",
        "mln",
        "inavir",
        "revenue",
        "milestone",
        "reuters",
        "staff",
        "april",
        "reuters",
        "vaxart",
        "inc",
        "vaxart",
        "announces",
        "million",
        "revenue",
        "milestone",
        "vaxart",
        "notified",
        "daiichi",
        "sankyo",
        "co",
        "sale",
        "inavir",
        "exceeded",
        "billion",
        "fiscal",
        "year",
        "triggering",
        "million",
        "milestone",
        "payment",
        "co",
        "vaxart",
        "inc",
        "payment",
        "expected",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}